These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23060098)

  • 21. Recruitment strategies and comparison of prostate cancer-specific clinical data on African-American and Caucasian males with and without family history.
    Mandal DM; Sartor O; Halton SL; Mercante DE; Bailey-Wilson JE; Rayford W
    Prostate Cancer Prostatic Dis; 2008; 11(3):274-9. PubMed ID: 18268528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer.
    Agalliu I; Karlins E; Kwon EM; Iwasaki LM; Diamond A; Ostrander EA; Stanford JL
    Br J Cancer; 2007 Sep; 97(6):826-31. PubMed ID: 17700570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-Genome Sequencing Reveals Elevated Tumor Mutational Burden and Initiating Driver Mutations in African Men with Treatment-Naïve, High-Risk Prostate Cancer.
    Jaratlerdsiri W; Chan EKF; Gong T; Petersen DC; Kalsbeek AMF; Venter PA; Stricker PD; Bornman MSR; Hayes VM
    Cancer Res; 2018 Dec; 78(24):6736-6746. PubMed ID: 30217929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct Genomic Alterations in Prostate Tumors Derived from African American Men.
    Liu W; Zheng SL; Na R; Wei L; Sun J; Gallagher J; Wei J; Resurreccion WK; Ernst S; Sfanos KS; Isaacs WB; Xu J
    Mol Cancer Res; 2020 Dec; 18(12):1815-1824. PubMed ID: 33115829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genome-wide copy number analysis reveals candidate gene loci that confer susceptibility to high-grade prostate cancer.
    Poniah P; Mohd Zain S; Abdul Razack AH; Kuppusamy S; Karuppayah S; Sian Eng H; Mohamed Z
    Urol Oncol; 2017 Sep; 35(9):545.e1-545.e11. PubMed ID: 28527622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymorphisms in CYP17 and CYP3A4 and prostate cancer in men of African descent.
    Taioli E; Sears V; Watson A; Flores-Obando RE; Jackson MD; Ukoli FA; de Syllos Cólus IM; Fernandez P; McFarlane-Anderson N; Ostrander EA; Rodrigues IS; Stanford JL; Taylor JA; Tulloch-Reid M; Ragin CC
    Prostate; 2013 May; 73(6):668-76. PubMed ID: 23129512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased copy-neutral loss of heterozygosity in African American colorectal cancers.
    Augustus GJ; Xicola RM; Llor X; Ellis NA
    Genes Chromosomes Cancer; 2020 Aug; 59(8):454-464. PubMed ID: 32293075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals.
    Platz EA; Rimm EB; Willett WC; Kantoff PW; Giovannucci E
    J Natl Cancer Inst; 2000 Dec; 92(24):2009-17. PubMed ID: 11121463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Segregation analysis of prostate cancer in 1,719 white, African-American and Asian-American families in the United States and Canada.
    Gong G; Oakley-Girvan I; Wu AH; Kolonel LN; John EM; West DW; Felberg A; Gallagher RP; Whittemore AS
    Cancer Causes Control; 2002 Jun; 13(5):471-82. PubMed ID: 12146852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate cancer susceptibility Loci identified on chromosome 12 in African Americans.
    Bonilla C; Hooker S; Mason T; Bock CH; Kittles RA
    PLoS One; 2011 Feb; 6(2):e16044. PubMed ID: 21358824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. R726L androgen receptor mutation is uncommon in prostate cancer families in the united states.
    Gruber SB; Chen H; Tomsho LP; Lee N; Perrone EE; Cooney KA
    Prostate; 2003 Mar; 54(4):306-9. PubMed ID: 12539229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rare Germline Copy Number Variations and Disease Susceptibility in Familial Melanoma.
    Shi J; Zhou W; Zhu B; Hyland PL; Bennett H; Xiao Y; Zhang X; Burke LS; Song L; Hsu CH; Yan C; Chen Q; Meerzaman D; Dagnall CL; Burdette L; Hicks B; Freedman ND; Chanock SJ; Yeager M; Tucker MA; Goldstein AM; Yang XR
    J Invest Dermatol; 2016 Dec; 136(12):2436-2443. PubMed ID: 27476724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA.
    Makridakis NM; Ross RK; Pike MC; Crocitto LE; Kolonel LN; Pearce CL; Henderson BE; Reichardt JK
    Lancet; 1999 Sep; 354(9183):975-8. PubMed ID: 10501358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for an association between prostate cancer and chromosome 8q24 and 10q11 genetic variants in African American men: the Flint Men's Health Study.
    Wang Y; Ray AM; Johnson EK; Zuhlke KA; Cooney KA; Lange EM
    Prostate; 2011 Feb; 71(3):225-31. PubMed ID: 20717903
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men.
    Freedman ML; Haiman CA; Patterson N; McDonald GJ; Tandon A; Waliszewska A; Penney K; Steen RG; Ardlie K; John EM; Oakley-Girvan I; Whittemore AS; Cooney KA; Ingles SA; Altshuler D; Henderson BE; Reich D
    Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14068-73. PubMed ID: 16945910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High burden of copy number alterations and c-MYC amplification in prostate cancer from BRCA2 germline mutation carriers.
    Castro E; Jugurnauth-Little S; Karlsson Q; Al-Shahrour F; Piñeiro-Yañez E; Van de Poll F; Leongamornlert D; Dadaev T; Govindasami K; Guy M; Eeles R; Kote-Jarai Z;
    Ann Oncol; 2015 Nov; 26(11):2293-300. PubMed ID: 26347108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing genetic risk at known prostate cancer susceptibility loci in African Americans.
    Haiman CA; Chen GK; Blot WJ; Strom SS; Berndt SI; Kittles RA; Rybicki BA; Isaacs WB; Ingles SA; Stanford JL; Diver WR; Witte JS; Chanock SJ; Kolb S; Signorello LB; Yamamura Y; Neslund-Dudas C; Thun MJ; Murphy A; Casey G; Sheng X; Wan P; Pooler LC; Monroe KR; Waters KM; Le Marchand L; Kolonel LN; Stram DO; Henderson BE
    PLoS Genet; 2011 May; 7(5):e1001387. PubMed ID: 21637779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary prostate cancer in African-American families.
    Cooney KA
    Semin Urol Oncol; 1998 Nov; 16(4):202-6. PubMed ID: 9858326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful recruitment of healthy African American men to genomic studies from high-volume community health fairs: implications for future genomic research in minority populations.
    Patel YR; Carr KA; Magjuka D; Mohammadi Y; Dropcho EF; Reed AD; Moore ML; Waddell MJ; Shedd-Steele R; Sweeney CJ; Hahn NM
    Cancer; 2012 Feb; 118(4):1075-82. PubMed ID: 21766294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship of early-onset baldness to prostate cancer in African-American men.
    Zeigler-Johnson C; Morales KH; Spangler E; Chang BL; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):589-96. PubMed ID: 23532004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.